Lista de obras - Francesco Vizzutti - Dominio Público Uruguay

ADMA correlates with portal pressure in patients with compensated cirrhosis.

artículo científico publicado en 2007

Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis.

artículo científico publicado en 2008

Adenosine monophosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells.

artículo científico publicado en 2008

Aggressive gastric carcinoma producing alpha-fetoprotein: a case report and review of the literature.

artículo científico

Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice.

artículo científico publicado en 2004

Ascites due to pericardial cyst

artículo científico publicado en 2009

Cardiovascular effects of canrenone in patients with preascitic cirrhosis.

artículo científico publicado en 2002

Curcumin limits the fibrogenic evolution of experimental steatohepatitis.

artículo científico publicado en 2009

Elastography for the non-invasive assessment of liver disease: limitations and future developments.

artículo científico publicado en 2009

Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis

artículo científico publicado en 2012

Elevated plasma levels of urotensin II do not correlate with systemic haemodynamics in patients with cirrhosis.

artículo científico publicado en 2010

Expanding the severity range of polytetrafluoroethylene-related hepatic outflow occlusion

artículo científico publicado en 2009

Farnesyltransferase inhibitor, ABT-100, is a potent liver cancer chemopreventive agent.

artículo científico publicado en 2005

Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis.

artículo científico publicado en 2001

Hepato-systemic gradient of carbon monoxide in cirrhosis.

artículo científico publicado en 2011

Increased plasma carbon monoxide in patients with viral cirrhosis and hyperdynamic circulation.

artículo científico publicado en 2009

Liver failure complicating segmental hepatic ischaemia induced by a PTFE-coated TIPS stent.

artículo científico publicado en 2009

Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis

artículo científico publicado en 2007

Non invasive diagnosis of portal hypertension in cirrhotic patients.

artículo científico publicado en 2008

Performance of Doppler ultrasound in the prediction of severe portal hypertension in hepatitis C virus-related chronic liver disease.

artículo científico publicado en 2007

Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease.

artículo científico publicado en 2008

Portal hypertension secondary to myelofibrosis: a study of three cases

scientific article published on 01 October 2005

Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice

article

Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C

scientific article published on 30 April 2008

Reply to the Letter to the Editor: “Reflection on the unsatisfactory model predicting mortality after TIPS in cirrhotic patients”

artículo científico publicado en 2022

Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease.

artículo científico publicado en 2010

Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells.

artículo científico publicado en 2009

Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography.

artículo científico publicado en 2008

Thrombopoietin stimulates migration and activates multiple signaling pathways in hepatoblastoma cells.

artículo científico publicado en 2005

Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells.

artículo científico publicado en 2005

Lista de obras de Francesco Vizzutti

ADMA correlates with portal pressure in patients with compensated cirrhosis.

Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis.

Adenosine monophosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells.

Aggressive gastric carcinoma producing alpha-fetoprotein: a case report and review of the literature.

Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice.

Ascites due to pericardial cyst

Cardiovascular effects of canrenone in patients with preascitic cirrhosis.

Curcumin limits the fibrogenic evolution of experimental steatohepatitis.

Elastography for the non-invasive assessment of liver disease: limitations and future developments.

Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis

Elevated plasma levels of urotensin II do not correlate with systemic haemodynamics in patients with cirrhosis.

Expanding the severity range of polytetrafluoroethylene-related hepatic outflow occlusion

Farnesyltransferase inhibitor, ABT-100, is a potent liver cancer chemopreventive agent.

Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis.

Hepato-systemic gradient of carbon monoxide in cirrhosis.

Increased plasma carbon monoxide in patients with viral cirrhosis and hyperdynamic circulation.

Liver failure complicating segmental hepatic ischaemia induced by a PTFE-coated TIPS stent.

Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis

Non invasive diagnosis of portal hypertension in cirrhotic patients.

Performance of Doppler ultrasound in the prediction of severe portal hypertension in hepatitis C virus-related chronic liver disease.

Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease.

Portal hypertension secondary to myelofibrosis: a study of three cases

Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice

Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C

Reply to the Letter to the Editor: “Reflection on the unsatisfactory model predicting mortality after TIPS in cirrhotic patients”

Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease.

Silybin, a component of sylimarin, exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells.

Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography.

Thrombopoietin stimulates migration and activates multiple signaling pathways in hepatoblastoma cells.

Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells.